NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Screening for and Management of Obesity and Overweight in Adults
Evidence Syntheses, No. 89
Investigators: Erin LeBlanc, MD, MPH, Elizabeth O'Connor, PhD, Evelyn P Whitlock, MD, MPH, Carrie Patnode, PhD, MPH, and Tanya Kapka, MD, MPH.
Structured Abstract
Background:
Overweight and obesity in adults are common and associated with cardiovascular risk and other adverse health effects.
Purpose:
To review benefits and harms of screening for and treatment of overweight and obesity in adults to assist the U.S. Preventive Services Task Force (USPSTF) in updating its 2003 recommendation.
Data Sources:
We searched MEDLINE, the Cochrane Central Registry of Controlled Trials, and PsycINFO from January 1, 2005 through September 9, 2010. Relevant trials published prior to 2005 were identified through good-quality systematic reviews.
Study Selection:
Two investigators independently reviewed 6,499 abstracts and 649 articles against a set of a priori inclusion criteria. Two investigators rated the quality of each study based on USPSTF methods. We included trials that involved behavioral-based treatment (38 trials, n=13,495) or the use of orlistat (18 trials, n=11,256) or metformin (3 trials, n=2,652) for weight loss or weight maintenance in adults in settings that are generalizable to U.S. primary care. Additional studies were included for the evaluation of weight loss treatment harms (4 additional behavioral trials, 6 additional orlistat trials, and 1 additional metformin trial).
Data Extraction:
Selected elements were abstracted into standardized tables from each study by one investigator and checked by another investigator.
Data Synthesis:
Data were qualitatively and quantitatively (using meta-analysis) synthesized separately for each type of intervention. Behavioral treatment resulted in an average weight loss of 3.0 kg more in intervention participants compared with control, with greater weight loss in trials with more treatment sessions (generally 4–7 kg lost in the intervention group in trials with 11–26 treatment sessions in the first year). Orlistat was additive to behavioral counseling, resulting in even greater weight loss (generally 6–9 kg total). Metformin trials were heterogeneous, but one large, good-quality trial showed a weight loss of 2.3 kg more in the intervention group. Weight loss treatments did not improve health outcomes, but they were sparsely reported and most trials were not powered for outcomes such as death and cardiovascular events. Weight loss treatment resulted in a reduction in diabetes incidence in two large, good-quality behavioral-based trials of diabetes prevention. Behavioral-based treatment showed small positive effects on blood pressure. Orlistat improved blood pressure and lowered low-density lipoprotein cholesterol (by 7–16 mg/dL) and plasma glucose (by 12 mg/dL in patients with diabetes) compared with placebo. Metformin did not improve lipid levels or blood pressure, but reduced the incidence of diabetes. Withdrawals due to adverse effects were more common among medication users than placebo users and were primarily related to gastrointestinal complaints.
Limitations:
There were minimal data on the distal health outcomes of death and cardiovascular disease. Many intermediate outcomes were sparsely reported, especially in the behavioral treatment literature. There were minimal data on behavioral-based treatment in people with class III obesity (body mass index >40 kg/m2). Behavioral-based treatments were heterogeneous and specific elements were not always well reported. Many medication trials had high attrition and most were conducted outside of the United States. There was one good-quality trial of orlistat and one of metformin but no data on maintenance of weight loss after medications were discontinued. Medication trials were not powered to identify group differences in rare but serious adverse effects.
Conclusions:
Behavioral-based treatments are safe and effective for weight loss, although they have not been studied in persons with class III obesity. Medication may increase weight loss beyond behavioral approaches alone, although side effects are common.
Contents
- 1. Introduction
- 2. Methods
- 3. Results
- KQ 1 Is There Direct Evidence That Primary Care Screening Programs for Adult Obesity or Overweight Improve Health Outcomes or Result in Short-Term or Sustained Weight Loss or Improved Physiological Measures?
- KQs 2–2b Do Primary Care–Relevant Interventions (Behavioral-Based Interventions and/or Pharmacotherapy) in Obese or Overweight Adults Lead to Improved Health Outcomes? What Are Common Elements of Efficacious Interventions? Are There Differences in Efficacy Between Patient Subgroups?
- KQs 3–3c Do Primary Care–Relevant Interventions in Obese or Overweight Adults Lead to Short-Term or Sustained Weight Loss, With or Without Improved Physiological Measures? How Well is Weight Loss Maintained After an Intervention is Completed? What Are Common Elements of Efficacious Interventions? Are There Differences in Efficacy Between Patient Subgroups?
- KQs 4 and 4a What Are the Adverse Effects of Primary Care–Relevant Interventions in Obese or Overweight Adults? Are There Differences in Adverse Effects Between Patient Subgroups?
- 4. Discussion
- Benefits of Screening for Adult Obesity
- Benefits of Weight Loss Treatment
- Clinical Health Outcomes
- Harms of Screening for Adult Obesity
- Harms of Weight Loss Treatment
- Effectiveness of Specific Weight Loss Strategies
- Applicability to Primary Care
- Cost/Cost Effectiveness
- Limitations of the Review
- Future Research
- References
- Appendixes
Acknowledgements: The authors acknowledge the EPC project team: Tracy L. Beil, MS, Catherine Livingston, MD, MPH, Kevin Lutz, MFA, Leslie A. Perdue, MPH, Daphne Plaut, MLS, Caitlyn A. Senger, MPH, Victor J. Stevens, PhD, and Sarah Zuber, MSW, for their contributions to this report.
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services1, Contract No. HHSA-290-02-0024. Prepared by: Oregon Evidence-based Practice Center2, Center for Health Research.
Suggested citation:
LeBlanc E, O'Connor E, Whitlock EP, Patnode C, Kapka T. Screening for and Management of Obesity and Overweight in Adults. Evidence Report No. 89. AHRQ Publication No. 11-05159-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; October 2011.
This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. HHSA-290-2007-10057-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.
This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
None of the authors have any affiliations or financial involvement that conflicts with the material presented in this report.
- 1
540 Gaither Road, Rockville, MD 20850; www
.ahrq.gov - 2
Kaiser Permanente Northwest, 3800 North Interstate Avenue, Portland, OR 97227
- Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force[ 2018]Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task ForceLeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. 2018 Sep
- Review Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force[ 2017]Review Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task ForcePatnode CD, Evans CV, Senger CA, Redmond N, Lin JS. 2017 Jul
- Review Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2014]Review Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task ForceLin JS, O'Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. 2014 Aug
- Review Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2016]Review Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task ForceLozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E. 2016 Aug
- Review Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2016]Review Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task ForceLozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi P, Whitlock EP. 2016 Aug
- Screening for and Management of Obesity and Overweight in AdultsScreening for and Management of Obesity and Overweight in Adults
Your browsing activity is empty.
Activity recording is turned off.
See more...